Oncovin and liver disorder Patient Reports March 20, 2010

Oncovin Side Effects Report #4648346-6
Oncovin side effect was reported by a Physician from on Apr 07, 2005. Female patient, 71 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: liver disorder. Oncovin dosage: 1.4 MG OTHER. During the same period patient was treated with CYCLOPHOSPHAMIDE, DAUNORUBICIN HYDROCHLORIDE, LEUNASE, GRAN. Patient recovered.

Oncovin Side Effects Report #4662759-8
Oncovin side effect was reported by a Physician from on Apr 26, 2005. Female patient, 71 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, laboratory test abnormal, liver disorder, neutrophil count decreased. Oncovin dosage: 1.4 MG OTHER. During the same period patient was treated with CYCLOPHOSPHAMIDE, DAUNORUBICIN HYDROCHLORIDE, LEUNASE, FAMOTIDINE, FIRSTCIN, ISEPACIN, KYTRIL. Patient recovered.

Oncovin Side Effects Report #4686991-2
Oncovin side effect was reported by a Physician from on May 24, 2005. Female patient, 71 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Oncovin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, neutropenia, platelet count decreased, venoocclusive liver disease. Oncovin dosage: 1.4 MG OTHER. During the same period patient was treated with CYCLOPHOSPHAMIDE, DAUNORUBICIN HYDROCHLORIDE, LEUNASE, FAMOTIDINE, FIRSTCIN, ISEPACIN, KYTRIL, MAXIPIME. Patient recovered.